[1]
S. M. Nur Husna, F. A. Hussain, M. M. Yahya, A. Dyhl-Polk, and K. K. Wong, “ANTI-HER2 ANTIBODIES IN COMBINATION WITH CHEMOTHERAPY OR CHEMOTHERAPY-FREE REGIMENS TARGETING HER2-POSITIVE BREAST CANCER: A SYSTEMATIC REVIEW”, MJPHM, vol. 20, no. 2, pp. 285-306, Oct. 2020.